Fauci Files Reveal a Mysterious NIAID Route: Click
The July 2026 Senate tranche known as the Fauci Files includes a September 10, 2020 email that routes FBI and inspector-general questions about Eco Health Alliance straight to one named official inside the National Institutes of Health. That single message, now public, shows how a grant-related inquiry was steered away from the institute that awarded the money and into the inbox of Michael Lauer, deputy director for extramural research at the Office of the Director. The record offers a concrete timestamp and named players, yet leaves open the question of why the referral happened and what it meant for the review that followed.
Document trail begins at OMA
The Office of Management and Analysis received a formal request for information from both the FBI and the Department of Health and Human Services Office of Inspector General. The request centered on two Eco Health Alliance awards that carried the grant numbers 1-R01AI110964-01 and 2-R01AI110964-06.
Instead of answering directly, OMA staff contacted NIAID. The institute responded by directing every detailed question to Lauer. An internal note recorded that NIAID had “been told to refer these detailed questions to you given the situation.”
The language suggests the instruction originated above the institute level, yet the email does not identify who issued it or when the standing order began.
Named players and their roles
Michelle G. Bulls, then working in the NIH Office of the Director, wrote the September 10 message to Lauer. She copied Jodi Black and summarized the referral in a few lines.
Lauer answered within hours. He agreed with the plan and suggested including the NIH Office of General Counsel, specifically attorney Anna Jacobs, in future conversations with OMA.
Both officials worked at the central NIH level rather than inside NIAID, placing the exchange above the laboratory that had originally funded the Eco Health work.
Restricted handling and limited record
The email thread carries an automatic notice that the conversation is restricted, meaning participants could forward messages but could not cut or copy text outside the controlled system.
Such markings are common for sensitive personnel or law-enforcement matters, yet they also limit the paper trail available to later reviewers.
The restriction notice itself appears in the released tranche, confirming that the conversation stayed inside official channels even as it moved between offices.
Timing within the larger timeline
September 2020 fell several months after the initial public controversy over NIH grants connected to Eco Health Alliance and the Wuhan Institute of Virology.
By then, congressional offices and federal watchdogs had begun asking for grant files, progress reports, and sub-award details. The FBI and OIG queries referenced in the email formed part of that widening review.
The referral to Lauer occurred while those external requests were still active, not after they had been resolved.
Scope of the questions being routed
Public summaries of the OIG and FBI inquiries at the time focused on whether Eco Health had properly reported its foreign sub-awards and whether the research met biosafety standards required by the grant terms.
The September 10 email does not list the exact items requested, but it notes that OMA sought information “for the OIG and FBI regarding Eco Health Alliance.”
Because the message treats the request as unusually sensitive, the referral appears tied to more than routine grant monitoring.
Why Lauer instead of NIAID staff
NIAID had administered the original awards, yet the institute’s own staff were told not to field detailed follow-up questions. The email states the standing instruction came “from the beginning,” implying an earlier decision that centralized such inquiries.
Placing Lauer in charge moved oversight to an office that reports directly to the NIH director and handles extramural policy across all institutes.
That shift concentrated decision-making authority at a level above the awarding institute.
Internal coordination steps that followed
Lauer’s reply proposed bringing in the Office of General Counsel, indicating that legal review was expected alongside any factual response to OIG and FBI.
He also scheduled a call with Ashley Sanders at OMA to “tell her the story behind the case,” suggesting that background context beyond the written record would be shared verbally.
These steps show an effort to manage both the documentary response and the narrative framing of the inquiry.
Unanswered questions that remain
The released email does not state who first directed NIAID to send such questions to Lauer, nor does it record whether similar routing applied to other grants under review at the same time.
Without additional messages or meeting notes, it is unclear how long the referral arrangement lasted or how it affected the final OIG and FBI assessments.
The gap leaves open the possibility that the handling reflected either standard practice for sensitive cases or a specific accommodation tied to this grant.
Access and verification going forward
The September 10 message sits in the Reading Room materials of the July 2026 Senate tranche. Researchers can compare it with other dated correspondence to test whether the referral pattern appears elsewhere.
Because the tranche includes both diary entries and email logs, cross-referencing timestamps may reveal whether verbal briefings mentioned by Lauer were later memorialized.
Until those additional records surface, the single email stands as the clearest available snapshot of how one FBI and OIG inquiry moved inside NIH.
Next steps for oversight
The document shows a defined internal route for sensitive grant questions, yet stops short of explaining the reasons behind that route. Future releases may clarify whether the arrangement protected deliberative processes, managed legal exposure, or served another purpose. For now, the email supplies a date, names, and a referral instruction that any follow-up review can use as a fixed reference point.
